TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2008

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.

Alex A Adjei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.